QOL a Crucial Consideration During R/R Myeloma Treatment Decision-Making
Patients with relapsed or refractory multiple myeloma should consider quality of life with survival when choosing the most suitable treatment option.
Fox Chase Cancer Center’s Jennifer Barsky Reese to Headline Webinar for the National Cancer Institute’s Office of Cancer Survivorship
